Swiss Res optimistic scenario estimates GLP-1 drugs could lead to a reduction in cumulative all-cause mortality in the US general population of 6.4% over the next 20 years For the UK, Swiss Res optimistic scenario forecasts a 5.1% cumulative reduction in all-cause mortality in the general population, over the same time horizon Achieving the full potential of GLP-1 drugs is strongly dependent on availability, adoption rates, lifestyle and nutritional changes 3 Likes laffisloon November 27, 2025, 7:20pm 2 A 4% drop would be 805.6 to 773.4
All IIH patients had elevated CSF opening pressure (mean 29.8 2.1 cmHO)
When people say they feel "tired" on semaglutide, they could be experiencing different types of fatigue: Physical weakness or low energy (most common): Feeling like everyday tasks require more effort Mental fatigue : Brain fog or difficulty concentrating Sleepiness : Actually feeling drowsy during the day Semaglutide-related fatigue is typically experienced as physical weakness or low energy rather than excessive sleepiness
However, heightened demand is resulting in lack of supply for patients who meet the clinical indications for these drugs
Ne pas croquer la capsule
Weight loss that happens with calorie restriction alone is not selective
